# OnCo record luveltamab-tazevibulin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/luveltamab-tazevibulin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "luveltamab-tazevibulin" ;
  schema:name "Luveltamab tazevibulin"@en ;
  schema:description "A folate-receptor ADC designed to work across low and high receptor levels, in a pivotal ovarian cancer trial."@en ;
  schema:url <https://onco.cc/drugs/luveltamab-tazevibulin/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05870748> ;
  onco:status "phase-3" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/site-specific-conjugation/> ;
  onco:targets <https://onco.cc/targets/folr1/> ;
  onco:companies <https://onco.cc/companies/sutro-biopharma/> ;
  onco:trials <https://onco.cc/trials/nct05870748/> .